| PERIOD ENDING | 27-Sep-09 | 28-Jun-09 | 29-Mar-09 | 31-Dec-08 | | Total Revenue | 11,187 | 8,068 | 5,572 | 13,065 | | Cost of Revenue | 8,722 | 9,677 | 13,487 | 12,468 | | | Gross Profit | 2,465 | (1,609) | (7,915) | 597 | | | Operating Expenses | | Research Development | 5,817 | 6,810 | 6,650 | 9,375 | | Selling General and Administrative | 11,611 | 11,505 | 12,854 | 19,715 | | Non Recurring | 1,738 | (100) | 918 | 30,881 | | Others |
-
|
-
|
-
| 128 | | | | Total Operating Expenses |
-
|
-
|
-
| 60,099 | | | | Operating Income or Loss | (16,701) | (19,824) | (28,337) | (59,502) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (219) | 205 | 1,305 | 702 | | Earnings Before Interest And Taxes | (16,920) | (19,619) | (27,032) | (58,800) | | Interest Expense | 30 | 23 | 33 | 31 | | Income Before Tax | (16,950) | (19,642) | (27,065) | (58,831) | | Income Tax Expense | (8,393) | 254 | 162 | 1,625 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (8,557) | (19,896) | (27,227) | (60,456) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (8,557) | (19,896) | (27,227) | (60,456) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($8,557) | ($19,896) | ($27,227) | ($60,456) |
|
0.06% Nasdaq 
Income Statement
